Bispecific Antibodies in Multiple Myeloma | Dana-Farber Cancer Institute
Ғылым және технология
Omar Nadeem, MD, explains bispecific antibodies as an exciting new immunotherapy treatment option for patients with relapsed or refractory multiple myeloma. Learn more about our Multiple Myeloma Program. www.dana-farber.org/multiple-...
Пікірлер: 1
DEAR EVERYONE AT DANA-FARBER CANCER INSTITUTE, HAPPY NEW YEAR. GOD BLESS YOU MY FRIENDS. I AM VERY PROUD OF YOU AND VERY HAPPY FOR YOU. I HOPE ALL OF YOUR DREAMS COME TRUE. I LOVE YOU. I LOVE DANA-FARBER CANCER INSTITUTE. 🙏 SINCERELY PETER